Myriad Genetics | MYGN - Debt


Myriad Genetics reported $59.3M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Agilent USD 3.41B 640M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Bruker USD 2.44B 321.5M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Exact Sciences USD 2.34B 15.24M Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.58B 22M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Quidel USD 2.79B 378.1M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.37B 5.86M Sep/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Veracyte USD 50.65M 145K Jun/2025
Waters USD 1.54B 36.51M Jun/2025